Showing results (51-60 of 258) with videos related to

Sort By:
Pageof 26
Cancer Medicine|March 5, 2021
Development of the CK-MB-1 trastuzumab-resistant HER2-positive breast cancer cell line and xenograft animal modelsWei-Pang Chung, Wei-Lun Huang, Wei-An Liao, et al.
Scientific Reports|March 2, 2021
Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumorsHui-Jen Tsai, Her-Shyong Shiah, Jang-Yang Chang, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|March 13, 2008
A new photothermal therapeutic agent: core-free nanostructured Au x Ag1-x dendritesKuo-Wei Hu, Chih-Chia Huang, Jih-Ru Hwu, et al.
International Journal of Cancer|May 3, 2018
Rab37 in lung cancer mediates exocytosis of soluble ST2 and thus skews macrophages toward tumor-suppressing phenotypeHong-Tai Tzeng, Ching-Chin Su, Chih-Peng Chang, et al.
International Journal of Nanomedicine|May 6, 2026
BIRC5 Promoter-Driven Nanodrugs Suppress BIRC5-Positive Cancers Independent of ABCB1 Status and IDO1 ExpressionYung-Chieh Chang, Wei-Lun Huang, Wu-Chou Su, et al.
Annals of Hematology|April 3, 2004
Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapyShiang Jiin Leaw, Chia Jui Yen, Wen Tsung Huang, et al.
Plos One|February 16, 2018
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasisWei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, et al.
Journal of Biomedical Science|February 6, 2024
Rab37 mediates trafficking and membrane presentation of PD-1 to sustain T cell exhaustion in lung cancerWan-Ting Kuo, I-Ying Kuo, Hung-Chia Hsieh, et al.
Lung Cancer (Amsterdam, Netherlands)|September 3, 2014
Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: adjusting quality-of-life and lead-time bias for utility of surgerySzu-Chun Yang, Wu-Wei Lai, Han-Yu Chang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2005
Prognostic significance of co-expression of RON and MET receptors in node-negative breast cancer patientsWen-Ying Lee, Helen H W Chen, Nan-Haw Chow, et al.
Pageof 26